False Claims Act Complaint Filed Against Regeneron Pharmaceuticals for Fraudulent Drug Pricing Reporting
Outcome
OIG enforcement action against False Claims Act Complaint Filed Against Regeneron Pharmaceuticals for Fraudulent Drug Pricing Reporting for false claims.
Details
False Claims Act Complaint Filed Against Regeneron Pharmaceuticals for Fraudulent Drug Pricing Reporting — OIG Enforcement (2026)
OIG took enforcement action against False Claims Act Complaint Filed Against Regeneron Pharmaceuticals for Fraudulent Drug Pricing Reporting in NY in 2026 involving false claims violations in the Independent Pharmacies sector.
Violation types: False Claims
Entity type: Pharmacy
Penalty type: Settlement
Location: NY
Source: False Claims Act Complaint Filed Against Regeneron Pharmaceuticals for Fraudulent Drug Pricing Reporting
How Crucible Prevents This
Crucible's billing compliance controls enforce documentation-to-claims reconciliation, requiring clinical attestation before claims submission and flagging billing patterns that deviate from documented care delivery.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works